311 related articles for article (PubMed ID: 29297703)
1. Cancer breath testing: a patent review.
Kabir KMM; Donald WA
Expert Opin Ther Pat; 2018 Mar; 28(3):227-239. PubMed ID: 29297703
[TBL] [Abstract][Full Text] [Related]
2. Detecting cancer by breath volatile organic compound analysis: a review of array-based sensors.
Queralto N; Berliner AN; Goldsmith B; Martino R; Rhodes P; Lim SH
J Breath Res; 2014 Jun; 8(2):027112. PubMed ID: 24862241
[TBL] [Abstract][Full Text] [Related]
3. Exhaled breath biopsy: a new cancer detection paradigm.
Abderrahman B
Future Oncol; 2019 May; 15(15):1679-1682. PubMed ID: 30977676
[No Abstract] [Full Text] [Related]
4. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis.
Sun X; Shao K; Wang T
Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028
[TBL] [Abstract][Full Text] [Related]
5. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
Zhou J; Huang ZA; Kumar U; Chen DDY
Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
[TBL] [Abstract][Full Text] [Related]
6. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
7. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
8. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
9. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
[TBL] [Abstract][Full Text] [Related]
10. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.
Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415
[TBL] [Abstract][Full Text] [Related]
11. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
12. Breath testing as a method for detecting lung cancer.
Taivans I; Bukovskis M; Strazda G; Jurka N
Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216
[TBL] [Abstract][Full Text] [Related]
13. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
Dallinga JW; Smolinska A; van Schooten FJ
Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
[TBL] [Abstract][Full Text] [Related]
14. VOC biomarkers identification and predictive model construction for lung cancer based on exhaled breath analysis: research protocol for an exploratory study.
Li W; Dai W; Liu M; Long Y; Wang C; Xie S; Liu Y; Zhang Y; Shi Q; Peng X; Liu Y; Li Q; Duan Y
BMJ Open; 2019 Aug; 9(8):e028448. PubMed ID: 31399453
[TBL] [Abstract][Full Text] [Related]
15. The Use of Selected Ion Flow Tube-Mass Spectrometry Technology to Identify Breath Volatile Organic Compounds for the Detection of Head and Neck Squamous Cell Carcinoma: A Pilot Study.
Chandran D; Ooi EH; Watson DI; Kholmurodova F; Jaenisch S; Yazbeck R
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31242578
[No Abstract] [Full Text] [Related]
16. Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath.
Riess U; Tegtbur U; Fauck C; Fuhrmann F; Markewitz D; Salthammer T
Anal Chim Acta; 2010 Jun; 669(1-2):53-62. PubMed ID: 20510903
[TBL] [Abstract][Full Text] [Related]
17. Sensors for breath testing: from nanomaterials to comprehensive disease detection.
Konvalina G; Haick H
Acc Chem Res; 2014 Jan; 47(1):66-76. PubMed ID: 23926883
[TBL] [Abstract][Full Text] [Related]
18. Exhaled breath analysis for early cancer detection: principle and progress in direct mass spectrometry techniques.
Badjagbo K
Clin Chem Lab Med; 2012 Nov; 50(11):1893-1902. PubMed ID: 22718640
[TBL] [Abstract][Full Text] [Related]
19. Progress in the development of volatile exhaled breath signatures of lung cancer.
Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
[TBL] [Abstract][Full Text] [Related]
20. Multimodal chemometric approach for the analysis of human exhaled breath in lung cancer patients by TD-GC × GC-TOFMS.
Pesesse R; Stefanuto PH; Schleich F; Louis R; Focant JF
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 May; 1114-1115():146-153. PubMed ID: 30745111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
